Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 2
1987 2
1988 3
1989 1
1990 1
1991 2
1992 2
1993 2
1995 1
1996 2
1998 1
1999 1
2002 3
2004 3
2005 1
2008 5
2009 3
2010 2
2011 4
2012 4
2013 7
2014 8
2015 11
2016 5
2018 4
2019 2
2021 1
2022 4
2023 3
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Results by year

Filters applied: . Clear all
Page 1
Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16.
Keenan TD, Agrón E, Domalpally A, Clemons TE, van Asten F, Wong WT, Danis RG, Sadda S, Rosenfeld PJ, Klein ML, Ratnapriya R, Swaroop A, Ferris FL 3rd, Chew EY; AREDS2 Research Group. Keenan TD, et al. Ophthalmology. 2018 Dec;125(12):1913-1928. doi: 10.1016/j.ophtha.2018.05.028. Epub 2018 Jul 27. Ophthalmology. 2018. PMID: 30060980 Free PMC article. Clinical Trial.
Globe and Adnexal Trauma Terminology Survey.
Hoskin AK, Fliotsos MJ, Rousselot A, Ng SMS, Justin GA, Blanch R, Colyer MH, Shukla B, Natarajan S, Kuhn F, Sundar G, Woreta FA, Watson SL, Agrawal R; International Globe and Adnexal Trauma Epidemiology Study (IGATES) Ophthalmic Trauma Terminology Consensus Group. Hoskin AK, et al. JAMA Ophthalmol. 2022 Aug 1;140(8):819-826. doi: 10.1001/jamaophthalmol.2022.2594. JAMA Ophthalmol. 2022. PMID: 35862061 Free PMC article.
Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4.
Age-Related Eye Disease Study 2 (AREDS2) Research Group; Chew EY, SanGiovanni JP, Ferris FL, Wong WT, Agron E, Clemons TE, Sperduto R, Danis R, Chandra SR, Blodi BA, Domalpally A, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Friberg TR, Rosenfeld PJ, Toth CA, Bernstein P. Age-Related Eye Disease Study 2 (AREDS2) Research Group, et al. Among authors: fish ge. JAMA Ophthalmol. 2013 Jul;131(7):843-50. doi: 10.1001/jamaophthalmol.2013.4412. JAMA Ophthalmol. 2013. PMID: 23645227 Free PMC article. Clinical Trial.
84 results